374 related articles for article (PubMed ID: 33264681)
41. Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
Nakahashi T; Arita T; Yamaji K; Inoue K; Yokota T; Hoshii Y; Fukunaga M; Nomura A; Watanabe H; Miura S; Isotani A; Soga Y; Ando K; Iwabuchi M; Yokoi H; Nosaka H; Yamagishi M; Nobuyoshi M
Int J Cardiol; 2014 Oct; 176(3):753-9. PubMed ID: 25131905
[TBL] [Abstract][Full Text] [Related]
42. Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?
Zhang C; Huang X; Li J
Blood Rev; 2017 Jul; 31(4):261-270. PubMed ID: 28336182
[TBL] [Abstract][Full Text] [Related]
43. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
44. A patient with AL amyloidosis with negative free light chain results.
Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
[TBL] [Abstract][Full Text] [Related]
45. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
[TBL] [Abstract][Full Text] [Related]
46. The Role of Standard Echocardiographic Parameters in Endomyocardial Biopsy Proven Cardiac Amyloidosis.
Biočić S; Jurinjak SJ; Vincelj J; Barić D; Manojlović S; Brkljačić DD
Coll Antropol; 2015 Jun; 39(2):441-5. PubMed ID: 26753463
[TBL] [Abstract][Full Text] [Related]
47. Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.
Halushka MK; Eng G; Collins AB; Judge DP; Semigran MJ; Stone JR
J Cardiovasc Transl Res; 2015 Jun; 8(4):264-8. PubMed ID: 25925232
[TBL] [Abstract][Full Text] [Related]
48. Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom.
Kon T; Nakagawa N; Yoshikawa F; Haba K; Kitagawa N; Izumi M; Kumazaki S; Ishida S; Aikawa R
Clin J Gastroenterol; 2016 Aug; 9(4):243-51. PubMed ID: 27318996
[TBL] [Abstract][Full Text] [Related]
49. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
[TBL] [Abstract][Full Text] [Related]
50. Light chain deposition disease presenting with gastrointestinal disorder as primary manifestation: report of two cases and literature review.
Wei C; Wang M; Li J; Su J; Huang J; Tong S; Yang D
J Int Med Res; 2024 Mar; 52(3):3000605241233972. PubMed ID: 38488658
[TBL] [Abstract][Full Text] [Related]
51. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
52. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
[TBL] [Abstract][Full Text] [Related]
53. Severe heart failure from light chain cardiomyopathy (cardiac amyloidosis).
Hofer JF; Wimmer G
Z Kardiol; 2003 Jan; 92(1):90-5. PubMed ID: 12545307
[TBL] [Abstract][Full Text] [Related]
54. Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.
Gallo G; Goñi F; Boctor F; Vidal R; Kumar A; Stevens FJ; Frangione B; Ghiso J
Am J Pathol; 1996 May; 148(5):1397-406. PubMed ID: 8623912
[TBL] [Abstract][Full Text] [Related]
55. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.
Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G
Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931
[TBL] [Abstract][Full Text] [Related]
56. Cardiac amyloid deposits in endomyocardial biopsies. Light microscopic, ultrastructural, and immunohistochemical studies.
Frenzel H; Schwartzkopff B; Kuhn H; Lösse B; Thormann J; Hort W; Linke RP
Am J Clin Pathol; 1986 Jun; 85(6):674-80. PubMed ID: 3518402
[TBL] [Abstract][Full Text] [Related]
57. A 64-year-old woman with raccoon eyes following kidney biopsy: a case report.
Mei S; Zhao Y; Li L; Mei C; Dai B
BMC Nephrol; 2020 Apr; 21(1):140. PubMed ID: 32303194
[TBL] [Abstract][Full Text] [Related]
58. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
59. Electron microscopy in patients with clinically suspected of cardiac amyloidosis who underwent endomyocardial biopsy and negative Congo red staining.
Cheng Z; Cui Q; Tian Z; Zhao D; Zhu K; Fang Q
Int J Cardiol; 2013 Oct; 168(3):3013-5. PubMed ID: 23643435
[No Abstract] [Full Text] [Related]
60. Liver transplantation for liver rupture due to light chain deposition disease: a case report.
Croitoru AG; Hytiroglou P; Schwartz ME; Saxena R
Semin Liver Dis; 2006 Aug; 26(3):298-303. PubMed ID: 16850379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
